Freenome, Inc. - Common stock (FRNM)

11.38
+0.14 (1.25%)
NASDAQ· Last Trade: Jul 27th, 6:19 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.24
Open11.81
Bid11.11
Ask11.70
Day's Range10.64 - 11.81
52 Week Range10.60 - 14.26
Volume1,449,123
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume655,551

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026